Health Canada Updates Medical Device Shortage Rules, What Manufacturers Should Prepare For

Regulatory Update | Medical Devices | October 2026

Medical-device shortages create serious challenges for healthcare systems, manufacturers, importers, and patients.

To strengthen Canada's ability to respond, Health Canada has updated its regulatory framework for device shortages and discontinuations, including new guidance for regulated parties. The update follows amendments to Canada's Medical Devices Regulations published on 17 June 2026; on 16 October 2026, Health Canada released updated guidance documents explaining how stakeholders should prepare for and comply with the amended requirements.

The changes matter most for manufacturers, Medical Device Establishment Licence (MDEL) holders, importers, distributors, and international companies supplying the Canadian market.

What's Changed?

The June 2026 amendments give Health Canada additional tools to address actual or anticipated shortages, including a framework for the exceptional importation and sale of medical devices.

Under it, a foreign-authorized device may be considered for addition to Health Canada's List of Medical Devices for Exceptional Importation and Sale where a shortage (or risk of shortage) of another device could present a risk of injury to human health. Listed devices may be temporarily imported and sold in Canada as substitutes, a potential pathway for international manufacturers to support continuity of supply when Canadian-authorized alternatives are unavailable.

Exceptional Importation and Sale

The updated Guide on the exceptional importation and sale of medical devices in response to shortages (GUI-0147), issued 7 October 2026, clarifies the framework's scope and updates the criteria for adding a designated device to the list.

Health Canada considers whether:

• There's a shortage or risk of shortage of a Canadian-authorized device

• The shortage could present a risk of injury to human health

• The foreign-authorized device can act as a substitute

• The device is authorized for sale elsewhere or complies with that jurisdiction's requirements

• The foreign-authorized device is manufactured to comparable standards

  
  

Important: this isn't a general alternative route for bringing any foreign device into Canada. It's a specific mechanism tied to shortage management and patient-health risks.

New Requirements for Importers

The framework also changes obligations for establishments involved in exceptional importation:

• MDEL holders must give advance notification at least three business days before importing a designated device

• Importers must notify Health Canada if they become aware of certain risks communicated in foreign jurisdictions (such as a recall) that could affect a designated device's safety or effectiveness.

  
  

That reinforces the need for strong communication across:

Manufacturer → Importer → MDEL Holder → Health Canada

An issue arising in another country can have direct implications for the Canadian supply chain.

Shortage Reporting Is Changing Too With a Transition Period

The amendments also change the reporting framework for shortages and discontinuations. The amended requirements come into force on 17 June 2027, one year after publication. Until then, existing reporting requirements remain in effect.

Health Canada has already issued Version 4 of GUI-0137 (Guide to reporting and providing information on medical device shortages and discontinuations) on 7 October 2026, to help regulated parties prepare.

Why the 2027 date matters: don't wait until June 2027 to review your processes. Health Canada distinguishes between:

• Actual shortages: current supply can't meet current demand

• Anticipated shortages: future supply may not meet projected demand

  
  

Regulatory planning shouldn't start only once a product is already unavailable. You need processes that can spot potential supply problems early enough to assess your obligations.

What Manufacturers Should Prepare

1. Review shortage monitoring procedures. Evaluate how you currently identify potential shortages in Canada, including monitoring of:

• Production capacity

• Supply-chain disruptions

• Component availability

• Inventory levels

• Forecasted demand

• Distribution constraints

• Planned discontinuations

  
  

2. Understand Canadian reporting obligations. Compare the updated GUI-0137 with your current procedures. With the new framework taking effect in June 2027, you have time to find gaps and update processes.

3. Review importer and MDEL responsibilities: Confirm which Canadian entity holds the relevant MDEL and what it's responsible for. Clear allocation avoids uncertainty when a shortage or discontinuation occurs.

4. Prepare for foreign risk notifications. If you use the exceptional importation framework, pay close attention to risks identified by foreign regulators. This makes international regulatory intelligence increasingly relevant to Canadian market access.

5. Review business continuity plans. A shortage response plan shouldn't focus solely on logistics. It should also cover:

Regulatory Notification → Alternative Supply → Importation Requirements → Risk Communication → Documentation → Follow-Up

What This Means for International Manufacturers

Canadian market access is connected to supply continuity and post-market responsibilities. A device authorized elsewhere can't simply be imported into Canada whenever a local shortage occurs. The exceptional importation framework offers a specific mechanism, but its conditions and responsibilities must still be met.

Understand how your Canadian partners manage:

• MDEL requirements and importation

• Shortage and discontinuation reporting

• Foreign regulatory developments

• Complaint handling and safety communications

• Documentation and communication with Health Canada

  
  

Also Coming: MDEL Licensing Changes

The shortage reforms coincide with broader changes to Canada's establishment licensing. Phase 2 of Health Canada's MDEL modernisation includes amendments coming into force on 14 December 2026. Among them:

• Certain foreign distributors will no longer need an MDEL when selling through Canadian importers that hold one

• Requirements for documented procedures will be clarified

• MDEL applicants and holders must provide a list of suppliers for the devices they import or distribute in Canada

  
  

For manufacturers working with Canadian distributors and importers, this is worth monitoring as the year closes.

Who Should Pay Attention?

• Medical-device manufacturers

• International manufacturers entering Canada

• Canadian importers and MDEL holders

• Distributors

• Regulatory affairs, supply-chain, and quality teams

• Companies managing foreign-authorized devices

• Businesses planning Canadian market entry

  
  

Companies whose products are critical to healthcare delivery should pay particular attention to shortage prevention and continuity planning.

ARQon Insight

Health Canada's updates highlight a growing principle in market access: regulatory strategy and supply-chain strategy can no longer be treated separately.

A product may have entered a market successfully, but manufacturers must also be ready for interrupted supply, shifting demand, or discontinuation. The Canadian framework also shows the value of regulatory intelligence across jurisdictions: a safety issue, recall, or regulatory action in another country can affect Canadian supply and obligations.

For international manufacturers, that means coordinated monitoring across:

Market Access → Supply → Safety → Regulatory Intelligence → Compliance

A Practical Preparation Plan

With key requirements taking effect in 2027, companies have time to prepare:

Step	Action
1. Map the supply chain	Identify manufacturers, importers, distributors, and MDEL holders for each device
2. Review shortage procedures	Assess how actual and anticipated shortages are identified and escalated
3. Assess the updated guidance	Compare current procedures against GUI-0137 and GUI-0147
4. Clarify responsibilities	Confirm who owns notifications, documentation, and regulatory communication
5. Strengthen international monitoring	Track foreign regulatory actions that could affect devices supplied in Canada
6. Prepare before June 2027	Update procedures and train teams before the new reporting rules take effect

Key Takeaway

Health Canada's October 2026 updates provide key guidance to prepare for Canada's changing device shortage framework. The exceptional importation and sale provisions are already in force following the June 2026 amendments, while the amended shortage and discontinuation reporting requirements take effect on 17 June 2027.

Preparing for a shortage is now part of regulatory planning. Don't wait for a disruption to decide who's responsible, what to report, or how to supply alternative devices. Early preparation supports compliance and continuity of patient care.

How ARQon Can Support You

ARQon supports healthcare and life-science companies with regulatory intelligence and market-access activities across international markets, including:

• Regulatory intelligence and monitoring

• Canadian market-entry strategy

• Medical-device regulatory pathway assessment

• MDEL and local-partner strategy

• Regulatory gap analysis

• Post-market compliance planning

• Supply-chain regulatory assessment

• Cross-border regulatory monitoring

• Market-access strategy

  
  

Stay Ahead. Stay Compliant. Stay Informed.

With ARQon Regulatory Intelligence.

Sources

Health Canada, Government of Canada:

• Updated guidance documents on medical device shortages, Medical Devices Compliance Bulletin, 16 October 2026

• Guide to reporting and providing information on medical device shortages and discontinuations (GUI-0137), Version 4, issued 7 October 2026

• Guide on the exceptional importation and sale of medical devices in response to shortages (GUI-0147), Version 2, issued 7 October 2026